Form 4 for MXCT MAXCYTE, INC.
Accepted 2022-11-03 00:00:00 ET · period of report 2022-11-01 · accession 0001209191-22-055528 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-11-03 | 2022-11-01+ | MXCT | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $0.8504 | +29.1K | 23.4K | New | +$24.8K |
| DM | 2022-11-03 | 2022-11-01+ | MXCT | Ross Thomas M. | EVP, Gbl Sales, Marketing | S - Sale+OE | $6.92 | -29.1K | 0 | -100% | -$201.7K |
| DM | 2022-11-03 | 2022-11-01+ | MXCT | Ross Thomas M. | EVP, Gbl Sales, Marketing | M - OptEx | $0.00 | -29.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-02 | M | A | 4,438 | $0.84 | 4,438 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-02 | S | D | 5,704 | $6.85 | 0 | D | — | — | (F4) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.72 to $6.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| 3 | Common | Common Stock | 2022-11-02 | M | A | 1,266 | $1.08 | 5,704 | D | — | — | (F3) This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant. |
| 4 | Common | Common Stock | 2022-11-01 | S | D | 23,429 | $6.94 | 0 | D | — | — | (F2) The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $6.80 to $7.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| 5 | Common | Common Stock | 2022-11-01 | M | A | 23,429 | $0.84 | 23,429 | D | — | — | |
| 6 | Derivative | Employee Stock Option (right to buy) | 2022-11-01 | M | D | 23,429 | $0.00 | 4,438 | D | $0.84 · — to 2026-01-10 | 23,429 Common Stock | (F5) This option is fully vested and exercisable. |
| 7 | Derivative | Employee Stock Option (right to buy) | 2022-11-02 | M | D | 1,266 | $0.00 | 60,734 | D | $1.08 · — to 2026-06-13 | 1,266 Common Stock | (F3) This exercise price is in U.S. Dollars and reflects the conversion of British pounds, the currency in which the exercise price was expressed at the time of grant. (F5) This option is fully vested and exercisable. |
| 8 | Derivative | Employee Stock Option (right to buy) | 2022-11-02 | M | D | 4,438 | $0.00 | 0 | D | $0.84 · — to 2026-01-10 | 4,438 Common Stock | (F5) This option is fully vested and exercisable. |